Cargando…
Consequences of Supraphysiological Dialysate Magnesium on Arterial Stiffness, Hemodynamic Profile, and Endothelial Function in Hemodialysis: A Randomized Crossover Study Followed by a Non-Controlled Follow-Up Phase
INTRODUCTION: Increasing dialysate magnesium (D-Mg(2+)) appears to be an intriguing strategy to obtain cardiovascular benefits in subjects with end-stage kidney disease (ESKD) on hemodialysis. To date, however, hemodialysis guidelines do not suggest to increase D-Mg(2+) routinely set at 0.50 mmol/L....
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595984/ https://www.ncbi.nlm.nih.gov/pubmed/32996010 http://dx.doi.org/10.1007/s12325-020-01505-9 |
_version_ | 1783602006474096640 |
---|---|
author | Del Giorno, Rosaria Lavorato Hadjeres, Soraya Stefanelli, Kevyn Allegra, Giampiero Zapparoli, Claudia Predrag, Lazarevic Berwert, Lorenzo Gabutti, Luca |
author_facet | Del Giorno, Rosaria Lavorato Hadjeres, Soraya Stefanelli, Kevyn Allegra, Giampiero Zapparoli, Claudia Predrag, Lazarevic Berwert, Lorenzo Gabutti, Luca |
author_sort | Del Giorno, Rosaria |
collection | PubMed |
description | INTRODUCTION: Increasing dialysate magnesium (D-Mg(2+)) appears to be an intriguing strategy to obtain cardiovascular benefits in subjects with end-stage kidney disease (ESKD) on hemodialysis. To date, however, hemodialysis guidelines do not suggest to increase D-Mg(2+) routinely set at 0.50 mmol/L. METHODS: A randomized 4-week crossover study aimed at investigating the consequences of increasing D-Mg(2+) from 0.50 to 0.75 mmol/L on arterial stiffness, hemodynamic profile, and endothelial function in subjects undergoing hemodialysis. The long-term effect of higher D-Mg(2+) on mineral metabolism markers was investigated in a 6-month follow-up. Data were analyzed by linear mixed models for repeated measures. RESULTS: Data of 39 patients were analyzed. Pulse wave velocity and pulse pressure significantly decreased on the higher D-Mg(2+) compared with the standard one by − 0.91 m/s (95% confidence interval − 1.52 to − 0.29; p = 0.01) and − 9.61 mmHg (− 18.89 to − 0.33, p = 0.04), respectively. A significant reduction in systolic blood pressure of − 12.96 mmHg (− 24.71 to − 1.22, p = 0.03) was also observed. No period or carryover effects were observed. During the long-term follow-up phase the higher D-Mg(2+) significantly increased ionized and total serum Mg (respectively from 0.54 to 0.64 and from 0.84 to 1.07 mmol/L; mean percentage change from baseline to follow-up + 21% and + 27%; p ≤ 0.001), while parathormone (PTH) decreased significantly (from 36.6 to 34.4 pmol/L; % change − 11%, p = 0.03). CONCLUSIONS: Increasing dialysate magnesium improves vascular stiffness in subjects undergoing maintenance hemodialysis. The present findings merit a larger trial to evaluate the effects of 0.75 mmol/L D-Mg(2+) on major clinical outcomes. TRIAL REGISTRATION: The study was retrospectively registered on the ISRCTN registry (ISRCTN 74139255) on 18 June 2020. |
format | Online Article Text |
id | pubmed-7595984 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-75959842020-11-10 Consequences of Supraphysiological Dialysate Magnesium on Arterial Stiffness, Hemodynamic Profile, and Endothelial Function in Hemodialysis: A Randomized Crossover Study Followed by a Non-Controlled Follow-Up Phase Del Giorno, Rosaria Lavorato Hadjeres, Soraya Stefanelli, Kevyn Allegra, Giampiero Zapparoli, Claudia Predrag, Lazarevic Berwert, Lorenzo Gabutti, Luca Adv Ther Original Research INTRODUCTION: Increasing dialysate magnesium (D-Mg(2+)) appears to be an intriguing strategy to obtain cardiovascular benefits in subjects with end-stage kidney disease (ESKD) on hemodialysis. To date, however, hemodialysis guidelines do not suggest to increase D-Mg(2+) routinely set at 0.50 mmol/L. METHODS: A randomized 4-week crossover study aimed at investigating the consequences of increasing D-Mg(2+) from 0.50 to 0.75 mmol/L on arterial stiffness, hemodynamic profile, and endothelial function in subjects undergoing hemodialysis. The long-term effect of higher D-Mg(2+) on mineral metabolism markers was investigated in a 6-month follow-up. Data were analyzed by linear mixed models for repeated measures. RESULTS: Data of 39 patients were analyzed. Pulse wave velocity and pulse pressure significantly decreased on the higher D-Mg(2+) compared with the standard one by − 0.91 m/s (95% confidence interval − 1.52 to − 0.29; p = 0.01) and − 9.61 mmHg (− 18.89 to − 0.33, p = 0.04), respectively. A significant reduction in systolic blood pressure of − 12.96 mmHg (− 24.71 to − 1.22, p = 0.03) was also observed. No period or carryover effects were observed. During the long-term follow-up phase the higher D-Mg(2+) significantly increased ionized and total serum Mg (respectively from 0.54 to 0.64 and from 0.84 to 1.07 mmol/L; mean percentage change from baseline to follow-up + 21% and + 27%; p ≤ 0.001), while parathormone (PTH) decreased significantly (from 36.6 to 34.4 pmol/L; % change − 11%, p = 0.03). CONCLUSIONS: Increasing dialysate magnesium improves vascular stiffness in subjects undergoing maintenance hemodialysis. The present findings merit a larger trial to evaluate the effects of 0.75 mmol/L D-Mg(2+) on major clinical outcomes. TRIAL REGISTRATION: The study was retrospectively registered on the ISRCTN registry (ISRCTN 74139255) on 18 June 2020. Springer Healthcare 2020-09-29 2020 /pmc/articles/PMC7595984/ /pubmed/32996010 http://dx.doi.org/10.1007/s12325-020-01505-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Original Research Del Giorno, Rosaria Lavorato Hadjeres, Soraya Stefanelli, Kevyn Allegra, Giampiero Zapparoli, Claudia Predrag, Lazarevic Berwert, Lorenzo Gabutti, Luca Consequences of Supraphysiological Dialysate Magnesium on Arterial Stiffness, Hemodynamic Profile, and Endothelial Function in Hemodialysis: A Randomized Crossover Study Followed by a Non-Controlled Follow-Up Phase |
title | Consequences of Supraphysiological Dialysate Magnesium on Arterial Stiffness, Hemodynamic Profile, and Endothelial Function in Hemodialysis: A Randomized Crossover Study Followed by a Non-Controlled Follow-Up Phase |
title_full | Consequences of Supraphysiological Dialysate Magnesium on Arterial Stiffness, Hemodynamic Profile, and Endothelial Function in Hemodialysis: A Randomized Crossover Study Followed by a Non-Controlled Follow-Up Phase |
title_fullStr | Consequences of Supraphysiological Dialysate Magnesium on Arterial Stiffness, Hemodynamic Profile, and Endothelial Function in Hemodialysis: A Randomized Crossover Study Followed by a Non-Controlled Follow-Up Phase |
title_full_unstemmed | Consequences of Supraphysiological Dialysate Magnesium on Arterial Stiffness, Hemodynamic Profile, and Endothelial Function in Hemodialysis: A Randomized Crossover Study Followed by a Non-Controlled Follow-Up Phase |
title_short | Consequences of Supraphysiological Dialysate Magnesium on Arterial Stiffness, Hemodynamic Profile, and Endothelial Function in Hemodialysis: A Randomized Crossover Study Followed by a Non-Controlled Follow-Up Phase |
title_sort | consequences of supraphysiological dialysate magnesium on arterial stiffness, hemodynamic profile, and endothelial function in hemodialysis: a randomized crossover study followed by a non-controlled follow-up phase |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595984/ https://www.ncbi.nlm.nih.gov/pubmed/32996010 http://dx.doi.org/10.1007/s12325-020-01505-9 |
work_keys_str_mv | AT delgiornorosaria consequencesofsupraphysiologicaldialysatemagnesiumonarterialstiffnesshemodynamicprofileandendothelialfunctioninhemodialysisarandomizedcrossoverstudyfollowedbyanoncontrolledfollowupphase AT lavoratohadjeressoraya consequencesofsupraphysiologicaldialysatemagnesiumonarterialstiffnesshemodynamicprofileandendothelialfunctioninhemodialysisarandomizedcrossoverstudyfollowedbyanoncontrolledfollowupphase AT stefanellikevyn consequencesofsupraphysiologicaldialysatemagnesiumonarterialstiffnesshemodynamicprofileandendothelialfunctioninhemodialysisarandomizedcrossoverstudyfollowedbyanoncontrolledfollowupphase AT allegragiampiero consequencesofsupraphysiologicaldialysatemagnesiumonarterialstiffnesshemodynamicprofileandendothelialfunctioninhemodialysisarandomizedcrossoverstudyfollowedbyanoncontrolledfollowupphase AT zapparoliclaudia consequencesofsupraphysiologicaldialysatemagnesiumonarterialstiffnesshemodynamicprofileandendothelialfunctioninhemodialysisarandomizedcrossoverstudyfollowedbyanoncontrolledfollowupphase AT predraglazarevic consequencesofsupraphysiologicaldialysatemagnesiumonarterialstiffnesshemodynamicprofileandendothelialfunctioninhemodialysisarandomizedcrossoverstudyfollowedbyanoncontrolledfollowupphase AT berwertlorenzo consequencesofsupraphysiologicaldialysatemagnesiumonarterialstiffnesshemodynamicprofileandendothelialfunctioninhemodialysisarandomizedcrossoverstudyfollowedbyanoncontrolledfollowupphase AT gabuttiluca consequencesofsupraphysiologicaldialysatemagnesiumonarterialstiffnesshemodynamicprofileandendothelialfunctioninhemodialysisarandomizedcrossoverstudyfollowedbyanoncontrolledfollowupphase |